About Averna Therapeutics
Averna Therapeutics is a private company based in Watertown, Massachusetts, incorporated in 2022 in Delaware. It has reported $84,999,995 raised in one offering on Form D since April 2024. Its chief executive is Thomas Barnes.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 8, 2024 | Apr 17, 2024amended Mar 20, 2026 | $84,999,995of $85.0M target | 13 | $6.5M | Equity, Options, Securities on exercise, Series A Convertible Preferred Stock, including underlying common shares ("Convertible Security Shares")Rule 506(b) | Form D/A ↗2 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Averna Therapeutics's Form D filed Mar 20, 2026.
Roy Amariglio
Board Member
SS
Stephen Squinto
Director
MS
Michal Silverberg
Director
Raju Prasad
Board Member
Henry Chen
Board Member
Dylan Morris
Board Member
Also a director at Gameto and ImmuneBridge and a managing director at insight partners at Superluminal Medicines.